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This study was conducted to determine the effects of dietary cholesterol (CHO) and cholesterol oxidation products (COPs) on the
induction of pathological lesions in rabbit liver tissues. Liver lesions were induced only when the levels of CHO and COPs in the
diet were very high.The amount of CHOmeasured in the liver increased when dietary CHOwas increased; by comparison, dietary
COPs affected liver CHO amounts to a lesser extent. The TBARS (thiobarbituric acid reactive substances) value measured for the
liver samples also increased when dietary CHO and COP levels were elevated, and the TBARS value was more strongly affected
by the amount of COPs in the diet than by the amount of CHO. At 6 and 12 weeks, COP levels were the highest in the group that
received 1.2 g CHO + 0.8 g COPs, followed by the 0.5 g CHO + 0.5 g COPs and 1.6 g CHO + 0.4 g COPs groups; the control (0 g)
group showed the lowest COP levels among all groups. In this study, we found that not only dietary CHO but also COPs were
involved in hypercholesterolemia induced liver lesions when the amount of CHO and COPs was high.
1. Introduction
Cholesterol (CHO) is a crucial component of the human
body, but a high level of CHO is considered amajor risk factor
for the development of atherosclerosis and coronary heart
disease (CHD) [1]. Moreover, the intake of cholesterol oxida-
tion products (COPs) also typically leads to the development
of atherosclerosis and CHD [2]. CHO is widely distributed in
living organisms and is localizedmainly in cell membranes in
its nonesterified form [3] and in the blood as a component of
lipoproteins mainly in its esterified form [4], and CHO plays
a role in numerous physiological and pathological processes.
CHO may be derived either from the diet or by means of
endogenous synthesis, which occurs primarily in the liver [4].
The liver is also the major site where CHO is removed by
being directly secreted into the bile or by being broken
down into bile acids; moreover, the liver plays a key role in
maintaining whole body CHO homeostasis by controlling
the uptake of extracellular CHO, CHO synthesis, and CHO
storage [5]. An elevated level of plasma CHO is typically a
risk factor for atherosclerosis, and several COPs are cytotoxic,
atherogenic, mutagenic, or carcinogenic; furthermore, COPs
injure endothelial cells, leading to atherosclerosis [1]. Alter-
ations in hepatic CHO homeostasis caused by dietary or drug
interventions potently influence CHO balance and plasma
low density lipoprotein (LDL) CHO levels in the body [6].
Thus, dietary CHO and COPs critically affect health because
LDL CHO levels are positively correlated with the risk of
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cardiovascular disease. Metabolic changes in liver tissues
serve as a barometer of the potential risk of atherosclerosis
and CHD, but the relationship between atherosclerosis and
metabolic changes in liver tissues, CHO type, and changes in
liver lipids is not well understood. In this study, our objective
was to determine the relationship between dietary CHO and
COPs and the induction of lesions in liver tissues and the
composition of CHO, COPs, TBARS, and fatty acids in the
liver tissues of rabbits.
2. Materials and Methods
2.1. Animal Diets and Experimental Protocol. We divided
64 young male New Zealand White rabbits (average weight
3 kg) into 8 groups. Each group was balanced with respect
to bodyweight by means of a restricted randomization tech-
nique, and the rabbits were housed individually in stainless
steel cages during the 3-month feeding trial. After 1 week
of acclimation, each group of rabbits was fed a commercial
rabbit chow containing no additives (0 g CHO+ 0 g COPs) or
chow containing, per kg diet, 1 g CHO, 2 g CHO, 0.9 g CHO+
0.1 g COPs, 0.8 g CHO+ 0.2 g COPs, 0.5 g CHO+ 0.5 g COPs,
1.6 g CHO + 0.4 g COPs, or 1.2 g CHO + 0.8 g COPs. Diets
were prepared at 2-week intervals and stored in a cold room
(0.5∘C) after vacuum packaging (1 bag/day). Four rabbits per
treatment were sacrificed bymeans of pentobarbital overdose
(200mg/kg bodyweight) after 45 and 90 days of feeding.
After liver sampling, the thorax was opened and liver tissues
were collected. Feeding, sample collection, and euthanasia
protocols were all approved by the Animal Care Committee
of Iowa State University and complied with the Care and the
Use of Laboratory Animals. The nutrient content of the basal
diet used in this study is listed in Table 6.
2.2. Preparation of Dietary COPs. COPs were prepared by
heating CHO with H
2
O
2
at 150∘C for 72 h. As evaluated
using gas chromatography (GC 6890, Agilent, Wilming-
ton, DE, USA) mass spectrometry, the final extract con-
tained 7𝛼-hydroxycholesterol (8.5%), 7𝛽-hydroxycholesterol
(14.8%), 5𝛼- and 6𝛼-epoxycholesterol (18.8%), 5𝛽- and 6𝛽-
epoxycholesterol (20.2%), a mixture of 6-ketocholesterol and
25-hydroxycholesterol (6.3%), and 7-ketocholesterol (24.8%).
2.3. Pathological Liver Lesions. Light microscopy was used to
determine the pathologic conditions and the degree of lesions
in liver tissues that were caused by the dietary treatments.
Liver tissues were fixed in 10% buffered formalin for 24 h,
washed for 4 h in tap water, dehydrated in an automated
processor, and embedded in paraffin. Next, 4 𝜇m thick
sections were cut and stained with hematoxylin and eosin
(HE), periodic acid-Schiff (PAS)-Alcian blue at pH 2.5, and
oil red O to observe the pathological lesions present in the
liver tissues.
2.4. Liver Cholesterol Analysis. We added 2 g of liver samples
to a 50mL tube containing 10mL of a saponification reagent
(30% KOH and ethanol at 6 : 94 ratio) and 0.5mL of an inter-
nal standard (2mg of 5𝛼-cholestane/sample) and homog-
enized the samples for 10 s using a Polytron homogenizer
(IKA Labortechnik T25-B, Staufen im Breisgau, Germany);
the tubes were then capped and the samples were incubated
for 1 h at 60∘C.After cooling, 8mLof deionized distilledwater
and 3mL of hexane were added and the samples were mixed
thoroughly and allowed to separate. The top layer (hexane
layer) was collected and dried in scintillation vials. Next,
100 𝜇L of bis-[trimethylsilyl]trifluoroacetamide (BSTFA) +
1% trimethylchlorosilane (TMCS) and 200𝜇L of pyridine
were added, and the samples were mixed and incubated
overnight and then were analyzed using gas chromatography
(GC 6890, Agilent). A ramped oven temperature condition
was used (180∘C for 2.5min, increased to 230∘C at 2.5∘C/min,
and then held at 230∘C for 7.5min), and the temperature of
both the inlet and the detector was 280∘C.Heliumwas used as
the carrier gas at a linear flow of 1.1mL/min; the detector-air
(flame ionization detector, FID), H
2
, and make-up gas (He)
flows were 350, 35, and 43mL/min, respectively.
2.5. Analysis of TBARS in Liver. A modified fluorometric
method [7] was used for tissue TBARS analysis. Each sample
(0.5mL of tissue homogenate in 4 vol. of water) was trans-
ferred into a 15-mL tube and mixed with 200mL of 8.1%
sodium dodecyl sulfate, 1.5mL of HCl, 1.5mL of 20mM thio-
barbituric acid, 50mL of butylated hydroxytoluene (BHT;
10% in 95% ethanol), and 250mL of double distilled water
(DDW). Samples were vortexed and then heated in a 90∘C
water bath for 15min. After cooling for 10min, 1mL of DDW
and 5mL of n-butanol/pyridine solution were added, and the
samples were mixed thoroughly and centrifuged at 3,000×g
for 15min. The fluorescence reading of the upper layer was
measured using a fluorometer at an excitation wavelength
of 520 nm and emission wavelength of 550 nm. TBARS
levels in liver tissues were expressed as mg malondialdehyde
(MDA)/kg tissues.
2.6. Analysis of COPs in Liver. The COPs present in the
liver were measured using a method described by Ahn
et al. [8]. Extracted lipids [9] were dissolved in hexane at
a final concentration of 0.1 g fat/mL hexane and used in the
following step. Amixture of silicic acid (100mesh), celite 545,
and CaHPO
4
(10 : 9 : 1, w/w/w) was prepared in chloroform
and packed into glass columns. The columns were washed
with 10mL of hexane : ethyl acetate (9 : 1 v/v, Solvent 1) before
loading samples. Lipid samples (0.2 g) dissolved in hexane
were mixed with an internal standard (5-𝛼-cholestane) and
loaded onto the silicic acid columns.Neutral lipids, CHO, and
phospholipids were eluted by passing hexane : ethyl acetate
(9 : 1, v/v) and hexane : ethyl acetate : diethyl ether (4 : 1 : 2,
v/v/v) through the column. Next, COPs were eluted using
acetone: ethyl acetate : methanol (10 : 10 : 1) and dried under
nitrogen. Dried COPs were added to 200𝜇L of pyridine and
100 𝜇L of BSTFA + 1% TMCS and derivatized by heating
in a dry bath (80∘C) for 1 h and analyzed using a gas
chromatography system (GC 6890, Agilent) equipped with
an on-column capillary injector and an FID. A ramped
oven temperature was used (180∘C for 2.5min, increased to
230∘C at 2.5∘C/min, and then held at 230∘C for 7.5min),
and the temperature of both the inlet and the detector was
280∘C. Helium was used as the carrier gas at a linear flow
BioMed Research International 3
of 1.1mL/min. The detector-air (FID), H
2
, and make-up gas
(He) flows were 350, 35, and 43mL/min, respectively. Fatty
acids were identified by comparing their retention times with
those of established standards, and their relative quantities
were expressed as the weight percent of total fatty acids.
2.7. Analysis of Liver Fatty Acids. The extracted lipids were
dissolved in hexane to obtain a final concentration of
0.1 g fat/mL hexane and were then used in the following
step. We added 1mL of hexane and 1mL of a methylating
reagent (3N-HCl in methanol) to 100 𝜇L of lipid extracts
(of liver) and incubated the samples at 90∘C in a water
bath for 1 h. After cooling to room temperature, 2mL of
hexane and 5mL of water were added to the samples, which
were mixed thoroughly and incubated at room temperature
overnight to allow phase separation. The top hexane layer
containing the methylated fatty acids was analyzed for fatty
acid composition by using a gas chromatograph (GC 6890,
Agilent). Gas chromatography conditions were the same as
those used for COPs analysis.
2.8. Statistical Analysis. Data were analyzed using SAS soft-
ware [10] by using the generalized linear model procedure.
The Student-Newman-Keuls multiple range tests were used
to compare differences among means. Mean values and
standard deviation of themean (STD) are reported. Statistical
significance was defined as 𝑃 < 0.05.
3. Results and Discussion
3.1. Pathological Lesions in Liver. The histopathological
results obtained are summarized in Table 1. The histopatho-
logical data (qualitative) indicated that the rabbits in the
groups that received 1.6 g CHO + 0.4 g COPs and 1.2 g
CHO + 0.8 g COPs exhibited the most severe vacuolation of
hepatocytes in the periacinar region of the hepatic lobule,
followed by the 2 g CHO group; however, the 0-g group
showed no abnormalities at 6 or 12 weeks. The rabbits that
were fed with the diets containing (per kg diet) 1 g CHO, 0.9 g
CHO + 0.1 g COPs, 0.8 g CHO + 0.2 g COPs, and 0.5 g CHO
+ 0.5 g COPs showed the least vacuolation of hepatocytes in
the periacinar region of the hepatic lobule at 6 and 12 weeks.
After 12 weeks, rabbits of the groups fed with 1.6 g CHO +
0.4 g COPs and 1.2 g CHO + 0.8 g COPs developed diffuse
severe vacuolation of hepatocytes throughout all areas of the
hepatic lobule and exhibited marked hepatocyte swelling.
3.2. Cholesterol Content in Liver. The liver CHO content
measured at 6 weeks and at the end of the experiment is
presented in Table 2. CHO content increased significantly
(𝑃 < 0.05) with an increase in dietary CHO and COPs in all
diet groups, but the CHOcontent did not change significantly
between feeding periods in the group that received 1.2 g
CHO + 0.8 g COPs. At both 6 and 12 weeks, high levels of
CHO in the diet significantly increased (𝑃 < 0.05) CHO
content in the liver compared with low levels of CHO in
the diet. The group that received 2 g CHO diet showed a
significantly higher (𝑃 < 0.05) CHO content in the liver
Table 1: Effect of dietary cholesterol and cholesterol oxidation
products on liver lesions: pathological lesions in liver.
Dietary
CHO1 + COPs g/kg diet 6 weeks 12 weeks
0 g
0
0
0
0
0
0
0
0
1 g chol.
+
+
+
+
+
+
+
+
2 g chol.
+
++
++
++++
++
++
++
+++
0.9 chol. + 0.1 COPs
+
+
+
+
+
+
+
+
0.8 chol. + 0.2 COPs
+
+
+
+
+
+
+
+
0.5 chol. + 0.5 COPs
+
+
+
+
+
+
+
+
1.6 chol. + 0.4 COPs
+
++
+++
++++
++
+++
+++
++++
1.2 chol. + 0.8 COPs
+
+++
+++
++++
++
+++
++++
++++
0: no abnormalities detected; +: mild vacuolation of hepatocytes in the
periacinar region of the hepatic lobule; ++: mild vacuolation of hepatocytes
in the periacinar and midzonal areas of the hepatic lobule; +++: moderate
vacuolation of cells in the periacinar andmidzonal areas of the hepatic lobule,
with affected cells showing diffuse vacuolation of the cytoplasm; ++++:
diffuse and severe vacuolation of hepatocytes in all areas of the hepatic lobule,
with marked swelling of the hepatocytes.
1CHO: natural cholesterol; COPs: cholesterol oxidation products.
than did all the other groups, because this diet contained the
highest amount of CHO among all the diets tested.
3.3. TBARS Contents in Liver. Table 3 shows the effect of
dietary CHO and COPs on TBARS values, which were used
as a measure of lipid oxidation in the liver.The TBARS values
in the liver increased significantly (𝑃 < 0.05) with an increase
in dietary intake of CHO andCOPs. TBARS values have been
shown to increase with lengthening of feeding periods. At
6 weeks, TBARS levels in the liver were significantly higher
(𝑃 < 0.05) in the 1.2 g CHO + 0.8 g COPs diet group than in
the other diet groups. At 12weeks, the 1.2 g CHO+0.4 gCOPs
diet group showed the highest levels of TBARS (𝑃 < 0.05),
followed by the 1.6 g CHO + 0.4 g COPs, 0.5 g CHO + 0.5 g
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Table 2: Effect of dietary cholesterol and cholesterol oxidation prod-
ucts on cholesterol content in liver.
Cholesterol in liver (mg/g)
Dietary
CHO1 + COPs g/kg diet 6 weeks 12 weeks SEM
0 g 1.123by 3.120az 0.156
1 g 3.231bx 16.727aw 0.405
2 g 17.795bv 27.735av 0.940
0.9 chol. + 0.1 COPs 2.787bx 10.737ax 0.813
0.8 chol. + 0.2 COPs 2.271bxy 9.004axy 0.714
0.5 chol. + 0.5 COPs 2.580bx 6.890ay 0.948
1.6 chol. + 0.4 COPs 11.072bw 16.218aw 0.894
1.2 chol. + 0.8 COPs 10.558w 11.665x 0.555
SEM 0.446 0.929 —
a and bDistinct letters within a row indicate significant differences (𝑃 < 0.05).
v,w,x,y, and zDistinct letters within a column indicate significant differences
(𝑃 < 0.05). 1CHO: natural cholesterol; COPs: cholesterol oxidation products.
Table 3: Effect of dietary cholesterol and cholesterol oxidation
products on TBARS in liver.
TBARS in liver (MA2 mg/kg)
Dietary
CHO1 + COPs g/kg diet 6 weeks 12 weeks SEM
0 g 0.564y 0.598y 0.024
1 g 0.691x 0.712x 0.016
2 g 0.736bx 0.832aw 0.021
0.9 chol. + 0.1 COPs 0.745x 0.740x 0.034
0.8 chol. + 0.2 COPs 0.695bx 0.833aw 0.032
0.5 chol. + 0.5 COPs 0.753bx 0.858aw 0.032
1.6 chol.+ 0.4 COPs 0.864w 0.874w 0.021
1.2 chol. + 0.8 COPs 0.968v 1.029v 0.020
SEM 0.032 0.016 —
a and bDistinct letters within a row indicate significant differences (𝑃 < 0.05).
v,w,x, and yDistinct letters within a column indicate significant differences
(𝑃 < 0.05). 1CHO: natural cholesterol; COPs: cholesterol oxidation products;
2MA: malonaldehyde.
COPs, 2 g CHO, and 0.8 g CHO + 0.2 g COPs diet groups,
and then the remaining diet groups.
3.4. Cholesterol Oxide Product Contents in Liver. Table 4
shows the effect of dietary CHOandCOPs onCOP content in
the liver. COP levels increased significantly (𝑃 < 0.05) with
an increase in feeding periods in all diet groups. Both at 6
and 12 weeks, COP levels were the highest (𝑃 < 0.05) in the
1.2 g CHO + 0.8 g COPs group, followed by the 0.5 g CHO +
0.5 g COPs group or 1.6 g CHO + 0.4 g COPs group; the 0 g
group showed the lowest COP levels (𝑃 < 0.05) among all
diet groups.
3.5. Fatty Acid Compositions in Liver. The composition of
fatty acids in the liver was markedly influenced by dietary
CHO and COPs (Table 5). Unsaturated fatty acids increased
substantially, whereas saturated fatty acids decreased consid-
erably. Dietary COPs more strongly affected the fatty acid
Table 4: Effect of dietary cholesterol and cholesterol oxidation
products on cholesterol oxidation products in liver.
COPs in liver (𝜇g/g)
Dietary
CHO1 + COPs g/kg diet 6 week 12 week SEM
0 g Trace 0.048z 0.003
1 g 0.030by 0.068ay 0.005
2 g 0.053bwx 0.109awx 0.006
0.9 chol. + 0.1 COPs 0.042bx 0.074ay 0.004
0.8 chol. + 0.2 COPs 0.055bw 0.094ax 0.005
0.5 chol. + 0.5 COPs 0.055bw 0.096awx 0.004
1.6 chol. + 0.4 COPs 0.054bwx 0.112aw 0.006
1.2 chol. + 0.8 COPs 0.082bv 0.146av 0.006
SEM 0.004 0.006 —
a and bDistinct letters within a row indicate significant differences (𝑃 < 0.05).
v,w,x,y, and zDistinct letters within a column indicate significant differences
(𝑃 < 0.05). 1CHO: natural cholesterol; COPs: cholesterol oxidation products.
composition in the liver than CHO did. The percentage of
palmitoleic acid and linolenic acid increased (𝑃 < 0.05),
whereas that of stearic acid decreased (𝑃 < 0.05) with an
increase in dietary CHO and COPs.
Hypercholesterolemia and hyperlipidemia caused by
dietary CHO and COP intake can potently influence lipid
metabolism in the liver. Gordon et al. [11] reported that
CHO-fed New Zealand White rabbits displayed distortions
in hepatic cellular architecture that resulted from severe fat
deposition in the liver. Subramanian et al. [12] also deter-
mined that dietary CHO induced a high degree of inflam-
mation, fibrosis, and hepatocyte injury in the mouse liver.
In this study, dietary CHO and COPs modified liver lipid
metabolism and induced liver lesions in rabbits; both COPs
and CHO induced pathological lesions in the liver when
their dietary levels were high (the total amount of CHO
and COPs was 2 g). Specifically, the amounts of COPs in the
diet exhibited a larger effect than CHO did on increasing
pathological lesions in the liver. Subramanian et al. [12] sug-
gested that the COPs generated by means of autooxidation or
enzymatic/nonenzymatic peroxidation of sterols also trigger
apoptosis and liver injury. We surmise that dietary CHO
and COPs, influenced largely by oxidative stress, affect the
induction of liver lesions. In this study, dietary CHO and
COPs increased lipid-oxidation values (TBARS) in the liver;
the amount of COPs in the diet exerted a stronger effect than
CHO did on increasing the TBARS values. Hurst et al. [13]
reported that cellular damage can be produced by various
activated species including superoxide, hydrogen peroxide,
peroxynitrite, and singlet oxygen. The peroxidation of mem-
brane lipids and the accumulation of lipid oxidation products
such as MDA and oxysterols generally induce spontaneous
oxidation of cellular cholesterol and trigger cell death [14].
Therefore, liver lesions were expected to be elevated when
TBARS values were increased as a result of including COPs
in the diet in this study.
COPs are more injurious to arterial cells than is pure
CHO, and COPs are more directly linked than CHO is to the
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Table 5: Effect of dietary cholesterol and cholesterol oxidation products on fatty acid composition in liver.
Fatty acid (%) 0 1 g CHO 2 g CHO 0.9 g CHO +0.1 g COPs
0.8 g CHO +
0.2 g COPs
0.5 g CHO +
0.5 g COPs
1.6 g CHO +
0.4 g COPs
1.2 g CHO +
0.8 g COPs SEM
Myristic acid 0d 0d 0.40c 0d 0d 0d 0.63a 0.47b 0.01
Palmitoleic acid 1.10e 1.95d 2.30bc 2.35bc 2.40bc 2.05cd 2.93a 2.66ab 0.1
Palmitic acid 20.46c 22.39a 20.82c 21.37b 21.81b 21.42b 19.27d 19.32d 0.18
Linoleic acid 29.42c 27.95d 31.41b 26.85e 27.96d 29.42c 31.11b 32.32a 0.31
Oleic acid 16.66c 20.03b 18.62b 21.5a 19.99b 18.95b 19.56b 18.99b 0.36
Linolenic acid 2.29b 3.34ab 3.57a 3.44ab 3.57a 3.78a 3.45ab 3.58a 0.13
Stearic acid 22.92a 18.18b 15.89c 18.67b 17.80b 17.84b 15.69c 15.56c 0.29
Arachidonic acid 6.27a 5.03c 5.63b 4.99c 5.17c 5.11c 5.54b 5.58b 0.12
Unidentified 0.90b 0.94ab 0.96ab 0.84bc 0.92ab 1.03a 0.79c 0.89bc 0.12
SFA/USFA2 43.38/55.74 40.57/58.30 37.11/61.53 40.04/59.13 39.61/59.09 39.26/59.31 35.59/62.59 35.26/63.13 —
a,b,c,d, and eDistinct letters within a row indicate significant differences (𝑃 < 0.05). 1CHO: natural cholesterol; COPs: cholesterol oxidation products. 2SFA:
saturated fatty acids; USFA: unsaturated fatty acids.
Table 6: Nutrient content of basal diet rabbit chow.
Nutrient Content (%)
Crude protein (min.) 16.0
Crude fat (min.) 1.5
Crude fiber (min.) 17.0
Calcium (min.–max.) 20.0
Phosphorous (min.) 0.6–1.1
Salt (NaCl) (min.–max.) 0.5–1.0
Vitamin A (min.) 4,400 IU/kg
Ingredients: processed grain byproducts, forage products, roughage prod-
ucts, plant protein products, grain products, molasses products, calcium
carbonate, salt, ferrous oxide, DL-methionine, choline chloride, vitamin E
supplement, calcium pantothenate, vitamin B-12 supplement, niacin supple-
ment, vitamin A supplement, manganese sulfate, vitamin D-3 supplement,
ferrous sulfate, cobalt carbonate, calcium iodate, copper sulfate, zinc sulfate,
magnesium oxide, and sodium selenite.
development of atherosclerosis and coronary heart disease
[15]. COPs also impair membrane function, which results
in altered membrane permeability [16]. Smith [17] reported
that natural CHO exerted no atherogenic or hypercholes-
terolemic effect and that CHO influenced the activities of
most enzymes to a lesser extent than COPs did. By contrast,
Kleemann et al. [18] reported that nutritional CHO itself may
contribute to the evolution of the inflammatory component of
atherogenesis, and that proatherogenic inflammatory factors
originated at least in part from the liver. Vejux and Lizard [14]
also reported that oxysterols potently induce apoptosis, and
that they can also induce necrosis in various cell types, with
this mode of cell death potentially being more pronounced
at high oxysterol concentrations. Our previous study [1]
showed that both dietary COPs and high CHO levels are
associated with an increased risk of atherosclerosis in rabbits,
and this study has revealed that not only dietary COPs
but also CHO induced pathological lesions in the liver. In
this study, hypercholesterolemia induced liver lesions when
the levels of dietary CHO and COPs were high (the total
amount of CHO and COPs was 2 g). Kleemann et al. [18] also
demonstrated that high-dose dietary CHO strongly induces
early atherosclerotic lesion formation in a mouse model.
These results indicate that the risks of liver lesions and
atherosclerotic lesions imposed by dietary CHO and COPs
are closely related and that hepatic lesions may be causatively
related to atherosclerosis.
Aghaei et al. [19] reported that dietary CHO markedly
altered fatty acid compositions in animal liver. This study
revealed that dietary CHO and COPs increased unsaturated
fatty acids and decreased saturated fatty acids.The percentage
of palmitoleic acid and linolenic acid increased (𝑃 < 0.05),
whereas that of stearic acid and arachidonic acid decreased
(𝑃 < 0.05) with an increase in dietary CHO and COPs.
The reason why unsaturated fatty acids are increased by
dietary CHO and COPs remains unclear, but the changes in
lipid composition induced by dietary CHO may be caused
by compensatory mechanisms initiated to maintain lipid
homeostasis in cellular aspects such as membrane fluidity
[20].
Unsaturated fatty acids are molecules that are typically
unsaturated or contain double bonds and are therefore
prone to oxidation [1]. Moreover, unsaturated fatty acids
are sensitive to free-radical oxidation caused by diatomic
molecular oxygen, and oxidized fatty acids play a major role
in the action of oxidized LDL [1]. Rudel et al. [21] reported
that LDL particles enriched in polyunsaturated fatty acids
are also easily oxidized in vitro. Therefore, dietary COPs and
CHO may influence the oxidation of unsaturated fatty acids
and thereby lead to an increase in liver lesions. In this study,
dietary COPs, compared with dietary CHO, more strongly
influenced fatty acid composition in the liver. Thus, oxidized
CHO may affect fatty acid oxidation and the formation of
liver lesions. Staprans et al. [22] reported that oxidized CHO
is absorbed and that it contributes to the pool of oxidized
lipids in circulating lipoproteins. When rabbits were fed
with oxidized CHO, fatty streak lesions in the aorta were
increased by 100% [22]. Staprans and coworkers hypothesized
that both diet-derived oxidized fatty acids in chylomicron
remnants and oxidized cholesterol in the remnants and in
LDL accelerate atherosclerosis by increasing oxidized lipid
6 BioMed Research International
levels in circulating LDL and chylomicron remnants. In this
regard, we surmise that increases in unsaturated fatty acid
levels are influenced largely by dietary COPs rather than
CHO, and that dietary COPs contribute to the oxidation of
CHO and liver lesions in rabbits. This is another possible
mechanism by which dietary COPs and high natural CHO
levels are associated with the increased risk of liver lesions in
rabbits. However, changes in fatty acid composition are not
influenced by only a single factor. Thus, additional studies
are required to understand the relationship between dietary
CHO or COPs and fatty acid composition in the liver.
4. Conclusion
CHO levels in the liver were significantly increased when
the amounts of dietary CHO were increased; by comparison,
increasing dietary COPs affected liver CHO levels to a lesser
extent. TBARS and COP levels in the liver were elevated with
increases in dietary CHOandCOPs, and the amount of COPs
in diet exerted a larger effect than CHO did on increasing the
contents of TBARS and COPs in the liver. The percentages
of palmitoleic acid and linolenic acid increased, whereas that
of stearic acid decreased with increasing dietary CHO and
COPs. In this study, we determined that not only dietary
CHO but also COPs were involved in hypercholesterolemia-
induced liver lesionswhen the amount ofCHOandCOPswas
high. However, dietary COPs exhibited a greater influence
than did CHO on liver cell damage.
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